Alan H Bryce (Alan Bryce, Ayca Dundar)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 49

Top Topics

African American

Radical Prostatectomy

Top Venues

Prostate cancer and prostatic diseases

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

The New England journal of medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Alan H Bryce, E David Crawford, Neeraj Agarwal, Maha H Hussain, Himisha Beltran, Matthew R Cooperberg, Daniel P Petrylak, Neal Shore, Daniel E Spratt, Scott T Tagawa, Emmanuel S Antonarakis, Ana M Aparicio, Andrew J Armstrong, Thomas P Boike, Jeremie Calais, Michael A Carducci, Brian F Chapin, Michael S Cookson, John W Davis, Tanya Dorff, Scott E Eggener, Felix Y Feng, Martin Gleave, Celestia Higano, Andrei Iagaru, Alicia K Morgans, Michael J Morris, Katie S Murray, Wendy Poage, Matthew B Rettig, Oliver Sartor, Howard I Scher, Paul Sieber, Eric Small, Sandy Srinivas, Evan Y Yu, Tian Zhang, Phillip J Koo
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2. JU open plus 2 (4) (2024)
Osama Mosalem, Winston Tan, Alan H Bryce, Roxana S Dronca, Daniel S Childs, Lance C Pagliaro, Jacob J Orme, Adam M Kase
A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis. Prostate cancer and prostatic diseases (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Neal D Shore, Emmanuel S Antonarakis, Ashley E Ross, Catherine H Marshall, Kelly L Stratton, Adanma Ayanambakkam, Michael S Cookson, Rana R McKay, Alan H Bryce, Marina D Kaymakcalan
Correction: A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2024)
Neal D Shore, Emmanuel S Antonarakis, Ashley E Ross, Catherine H Marshall, Kelly L Stratton, Adanma Ayanambakkam, Michael S Cookson, Rana R McKay, Alan H Bryce, Marina D Kaymakcalan
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Neal D Shore, Emmanuel S Antonarakis, Ashley Ross, Catherine Marshall, Kelly Stratton, Adanma Ayanambakkam, Michael Cookson, Rana R McKay, Alan H Bryce, Marina Kaymakcalan
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Neal D Shore, Emmanuel S Antonarakis, Ashley E Ross, Catherine H Marshall, Kelly L Stratton, Adanma Ayanambakkam, Michael S Cookson, Rana R McKay, Alan H Bryce, Marina D Kaymakcalan
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2024)
Alan H Bryce, E David Crawford, Neeraj Agarwal, Maha H Hussain, Himisha Beltran, Matthew R Cooperberg, Daniel P Petrylak, Neal Shore, Daniel E Spratt, Scott T Tagawa, Emmanuel S Antonarakis, Ana M Aparicio, Andrew J Armstrong, Thomas P Boike, Jeremie Calais, Michael A Carducci, Brian F Chapin, Michael S Cookson, John W Davis, Tanya Dorff, Scott E Eggener, Felix Y Feng, Martin Gleave, Celestia Higano, Andrei Iagaru, Alicia K Morgans, Michael J Morris, Katie S Murray, Wendy Poage, Matthew B Rettig, Oliver Sartor, Howard I Scher, Paul Sieber, Eric Small, Sandy Srinivas, Evan Y Yu, Tian Zhang, Phillip J Koo
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2. JU open plus 2 (4) (2024)
Alan H Bryce, E David Crawford, Neeraj Agarwal, Maha H Hussain, Himisha Beltran, Matthew R Cooperberg, Daniel P Petrylak, Neal Shore, Daniel E Spratt, Scott T Tagawa, Emmanuel S Antonarakis, Ana M Aparicio, Andrew J Armstrong, Thomas P Boike, Jeremie Calais, Michael A Carducci, Brian F Chapin, Michael S Cookson, John W Davis, Tanya Dorff, Scott E Eggener, Felix Y Feng, Martin Gleave, Celestia Higano, Andrei Iagaru, Alicia K Morgans, Michael J Morris, Katie S Murray, Wendy Poage, Matthew B Rettig, Oliver Sartor, Howard I Scher, Paul Sieber, Eric Small, Sandy Srinivas, Evan Y Yu, Tian Zhang, Phillip J Koo
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2. JU open plus 2 (4) (2024)
Neal D Shore, Emmanuel S Antonarakis, Ashley E Ross, Catherine H Marshall, Kelly L Stratton, Adanma Ayanambakkam, Michael S Cookson, Rana R McKay, Alan H Bryce, Marina D Kaymakcalan
Correction: A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2024)
Neal D Shore, Emmanuel S Antonarakis, Ashley Ross, Catherine Marshall, Kelly Stratton, Adanma Ayanambakkam, Michael Cookson, Rana R McKay, Alan H Bryce, Marina Kaymakcalan
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2024)
Rahul R Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Barauskas Dorff, Leonard J Appleman, Douglas Weckstein, Akash Patnaik, Alan H Bryce, Daniel Shevrin, James L Mohler, Daniel Anderson, Arpit Rao, Scott T Tagawa, Alan Tan, Susan Halabi, Katharine E Dooley, Patrick O'Brien, Ronald C Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, null null
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Karim Fizazi, Josep M Piulats, M Neil Reaume, Peter Ostler, Ray McDermott, Joel R Gingerich, Elias Pintus, Srikala S Sridhar, Richard M Bambury, Urban Emmenegger, Henriette Lindberg, David Morris, Franco Nolè, John Staffurth, Charles Redfern, María I Sáez, Wassim Abida, Gedske Daugaard, Axel Heidenreich, Laurence Krieger, Brieuc Sautois, Andrea Loehr, Darrin Despain, Catherine A Heyes, Simon P Watkins, Simon Chowdhury, Charles J Ryan, Alan H Bryce, null null
Rucaparib or Physician's Choice in Metastatic Prostate Cancer. The New England journal of medicine (2023)
Mohamed E Ahmed, Matthew S Lee, Ahmed M Mahmoud, Vidhu B Joshi, Ajay Gopalakrishna, Raevti Bole, Rimki Haloi, A Tuba Kendi, Michael S Bold, Alan H Bryce, Robert Jeffrey Karnes, Eugene D Kwon, Daniel S Childs, Jack R Andrews
Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant prostate cancer. Prostate cancer and prostatic diseases (2023)
Suryadipto Sarkar, Kong Min, Waleed Ikram, Ryan W Tatton, Irbaz B Riaz, Alvin C Silva, Alan H Bryce, Cassandra Moore, Thai H Ho, Guru P Sonpavde, Haidar M Abdul-Muhsin, Parminder Singh, Teresa Wu
Performing Automatic Identification and Staging of Urothelial Carcinoma in Bladder Cancer Patients Using a Hybrid Deep-Machine Learning Approach. Cancers 15 (6) (2023)
Michael J Morris, Glenn Heller, David W Hillman, Olivia Bobek, Charles Ryan, Emmanuel S Antonarakis, Alan H Bryce, Olwen Hahn, Himisha Beltran, Andrew J Armstrong, Lawrence Schwartz, Lionel D Lewis, Jan H Beumer, Brooke Langevin, Eric C McGary, Paul T Mehan, Amir Goldkorn, Bruce J Roth, Han Xiao, Colleen Watt, Mary-Ellen Taplin, Susan Halabi, Eric J Small
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Karan K Budhraja, Bradon R McDonald, Michelle D Stephens, Tania Contente-Cuomo, Havell Markus, Maria Farooq, Patricia F Favaro, Sydney Connor, Sara A Byron, Jan B Egan, Brenda J Ernst, Timothy K McDaniel, Aleksandar Sekulic, Nhan L Tran, Michael D Prados, Mitesh J Borad, Michael E Berens, Barbara A Pockaj, Patricia M LoRusso, Alan H Bryce, Jeffery M Trent, Muhammed Murtaza
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer. Science translational medicine 15 (678) (2023)
Holly M Thomson, Shannon P Fortin Ensign, Victoria S Edmonds, Akanksha Sharma, Richard J Butterfield, Steven E Schild, Jonathan B Ashman, Richard S Zimmerman, Naresh P Patel, Alan H Bryce, Sujay A Vora, Terence T Sio, Alyx B Porter
Clinical Outcomes of Stereotactic Radiosurgery-Related Radiation Necrosis in Patients with Intracranial Metastasis from Melanoma. Clinical Medicine Insights. Oncology 17 (2023)
Suryadipto Sarkar, Kong Min, Waleed Ikram, Ryan W Tatton, Irbaz B Riaz, Alvin C Silva, Alan H Bryce, Cassandra Moore, Thai H Ho, Guru P Sonpavde, Haidar M Abdul-Muhsin, Parminder Singh, Teresa Wu
Performing Automatic Identification and Staging of Urothelial Carcinoma in Bladder Cancer Patients Using a Hybrid Deep-Machine Learning Approach. Cancers 15 (6) (2023)
Holly M Thomson, Shannon P Fortin Ensign, Victoria S Edmonds, Akanksha Sharma, Richard J Butterfield, Steven E Schild, Jonathan B Ashman, Richard S Zimmerman, Naresh P Patel, Alan H Bryce, Sujay A Vora, Terence T Sio, Alyx B Porter
Clinical Outcomes of Stereotactic Radiosurgery-Related Radiation Necrosis in Patients with Intracranial Metastasis from Melanoma. Clinical Medicine Insights. Oncology 17 (2023)
Karim Fizazi, Josep M Piulats, M Neil Reaume, Peter Ostler, Ray McDermott, Joel R Gingerich, Elias Pintus, Srikala S Sridhar, Richard M Bambury, Urban Emmenegger, Henriette Lindberg, David Morris, Franco Nolè, John Staffurth, Charles Redfern, María I Sáez, Wassim Abida, Gedske Daugaard, Axel Heidenreich, Laurence Krieger, Brieuc Sautois, Andrea Loehr, Darrin Despain, Catherine A Heyes, Simon P Watkins, Simon Chowdhury, Charles J Ryan, Alan H Bryce, null null
Rucaparib or Physician's Choice in Metastatic Prostate Cancer. The New England journal of medicine 388 (8) (2023)
Karan K Budhraja, Bradon R McDonald, Michelle D Stephens, Tania Contente-Cuomo, Havell Markus, Maria Farooq, Patricia F Favaro, Sydney Connor, Sara A Byron, Jan B Egan, Brenda J Ernst, Timothy K McDaniel, Aleksandar Sekulic, Nhan L Tran, Michael D Prados, Mitesh J Borad, Michael E Berens, Barbara A Pockaj, Patricia M LoRusso, Alan H Bryce, Jeffery M Trent, Muhammed Murtaza
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer. Science translational medicine 15 (678) (2023)
Karim Fizazi, Josep M Piulats, M Neil Reaume, Peter Ostler, Ray McDermott, Joel R Gingerich, Elias Pintus, Srikala S Sridhar, Richard M Bambury, Urban Emmenegger, Henriette Lindberg, David Morris, Franco Nolè, John Staffurth, Charles Redfern, María I Sáez, Wassim Abida, Gedske Daugaard, Axel Heidenreich, Laurence Krieger, Brieuc Sautois, Andrea Loehr, Darrin Despain, Catherine A Heyes, Simon P Watkins, Simon Chowdhury, Charles J Ryan, Alan H Bryce, null null
Rucaparib or Physician's Choice in Metastatic Prostate Cancer. The New England journal of medicine 388 (8) (2023)
Karan K Budhraja, Bradon R McDonald, Michelle D Stephens, Tania Contente-Cuomo, Havell Markus, Maria Farooq, Patricia F Favaro, Sydney Connor, Sara A Byron, Jan B Egan, Brenda J Ernst, Timothy K McDaniel, Aleksandar Sekulic, Nhan L Tran, Michael D Prados, Mitesh J Borad, Michael E Berens, Barbara A Pockaj, Patricia M LoRusso, Alan H Bryce, Jeffery M Trent, Muhammed Murtaza
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer. Science translational medicine 15 (678) (2023)
Karim Fizazi, Josep M Piulats, M Neil Reaume, Peter Ostler, Ray McDermott, Joel R Gingerich, Elias Pintus, Srikala S Sridhar, Richard M Bambury, Urban Emmenegger, Henriette Lindberg, David Morris, Franco Nolè, John Staffurth, Charles Redfern, María I Sáez, Wassim Abida, Gedske Daugaard, Axel Heidenreich, Laurence Krieger, Brieuc Sautois, Andrea Loehr, Darrin Despain, Catherine A Heyes, Simon P Watkins, Simon Chowdhury, Charles J Ryan, Alan H Bryce, null null
Rucaparib or Physician's Choice in Metastatic Prostate Cancer. The New England journal of medicine 388 (8) (2023)
Alan H Bryce, David D Thiel, Michael V Seiden, Donald Richards, Ying Luan, Marie V Coignet, Quan Zhang, Nan Zhang, Earl Hubbell, Kathryn N Kurtzman, Eric E Klein
Performance of a Cell-Free DNA-Based Multi-cancer Detection Test in Individuals Presenting With Symptoms Suspicious for Cancers. JCO precision oncology 7 (2023)
Karan K Budhraja, Bradon R McDonald, Michelle D Stephens, Tania Contente-Cuomo, Havell Markus, Maria Farooq, Patricia F Favaro, Sydney Connor, Sara A Byron, Jan B Egan, Brenda J Ernst, Timothy K McDaniel, Aleksandar Sekulic, Nhan L Tran, Michael D Prados, Mitesh J Borad, Michael E Berens, Barbara A Pockaj, Patricia M LoRusso, Alan H Bryce, Jeffery M Trent, Muhammed Murtaza
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer. Science translational medicine 15 (678) (2023)
Alicia K Morgans, Yu-Hui Chen, David F Jarrard, Michael Carducci, Glenn Liu, Mario Eisenberger, Elizabeth R Plimack, Alan H Bryce, Jorge A Garcia, Robert Dreicer, Nicholas J Vogelzang, Joel Picus, Daniel Shevrin, Maha Hussain, Robert S DiPaola, David Cella, Christopher J Sweeney, null null
Association between baseline body mass index and survival in men with metastatic hormone-sensitive prostate cancer: ECOG-ACRIN CHAARTED E3805. The Prostate 82 (12) (2022)
Alex J Liu, Heidi E Kosiorek, Benjamin E Ueberroth, Ellen Jaeger, Elisa M Ledet, Ayse T Kendi, Katherine Tzou, Fernando Quevedo, Richard Choo, Cassandra N Moore, Thai H Ho, Parminder Singh, Sameer R Keole, William W Wong, A Oliver Sartor, Alan H Bryce
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases. The Prostate 82 (12) (2022)
Christopher T Su, Emily Nizialek, Jacob E Berchuck, Panagiotis J Vlachostergios, Ryan Ashkar, Alexandra O Sokolova, Pedro C Barata, Rahul R Aggarwal, Rana R McKay, Neeraj Agarwal, Heather M McClure, Nellie N Nafissi, Alan H Bryce, A Oliver Sartor, Nicolas Sayegh, Heather H Cheng, Nabil Adra, Cora N Sternberg, Mary-Ellen Taplin, Marcin Cieslik, Ajjai S Alva, Emmanuel S Antonarakis
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer. The Prostate (2022)
Brooke R Druliner, Krishna R Kalari, Sisi Qin, Scott M Dehm, Vipul Bhargava, Michael Gormley, Winston Tan, Jason P Sinnwell, David W Hillman, Ying Li, Peter T Vedell, Rachel E Carlson, Alan H Bryce, Raphael E Jimenez, Richard M Weinshilboum, Manish Kohli, Liewei Wang
Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment. Molecular cancer research : MCR 20 (12) (2022)
Zhuoer Xie, Antoine N Saliba, Jithma Abeykoon, Umair Majeed, Daniel R Almquist, Julia E Wiedmeier, Evandro Bezerra, Xavier Andrade-Gonzalez, Ashley Hickman, Karl Sorenson, Sagar Rakshit, Christopher E Wee, Sri Harsha Tella, Anuhya Kommalapati, Nadine Abdallah, Joshua C Pritchett, Mariza De Andrade, Dipesh Uprety, Andrew Badley, Rami Manochakian, Sikandar Ailawadhi, Alan H Bryce, Joleen M Hubbard, Naseema Gangat, Carrie A Thompson, Thomas E Witzig, Robert R McWilliams, Konstantinos Leventakos, Thorvardur R Halfdanarson
Outcomes of COVID-19 in Patients With Cancer: A Closer Look at Pre-Emptive Routine Screening Strategies. JCO oncology practice 17 (9) (2021)
Aaron S Mansfield, David S Hong, Christine L Hann, Anna F Farago, Himisha Beltran, Saiama N Waqar, Andrew E Hendifar, Lowell B Anthony, Matthew H Taylor, Alan H Bryce, Scott T Tagawa, Karl Lewis, Jiaxin Niu, Christine H Chung, James M Cleary, Michael Rossi, Carrianne Ludwig, Ricardo Valenzuela, Yan Luo, Rahul R Aggarwal
A phase I/II study of rovalpituzumab tesirine in delta-like 3-expressing advanced solid tumors. NPJ precision oncology 5 (1) (2021)
Elisa M Ledet, Earle F Burgess, Alexandra O Sokolova, Ellen B Jaeger, Whitley Hatton, Marcus Moses, Patrick Miller, Patrick Cotogno, Jodi Layton, Pedro Barata, Brian E Lewis, Mari Nakazawa, Jason Zhu, Beth Dellinger, Sara Elrefai, Nellie N Nafissi, Jan B Egan, Neal Shore, Rana R McKay, Alan H Bryce, Heather H Cheng, Emmanuel S Antonarakis, A Oliver Sartor
Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer. The Prostate 81 (7) (2021)
Masaya Jimbo, Jack R Andrews, Mohamed E Ahmed, Alan H Bryce, R Jeffrey Karnes, Alan H Bryce, Ayse T Kendi, Eugene D Kwon, Val J Lowe, Michael S Bold
Prognostic role of 11C-choline PET/CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapy. The Prostate 82 (1) (2021)
Fadi Taza, Albert E Holler, Wei Fu, Hao Wang, Nabil Adra, Costantine Albany, Ryan Ashkar, Heather H Cheng, Alexandra O Sokolova, Archana M Agarwal, Adam Kessel, Alan H Bryce, Nellie Nafissi, Pedro C Barata, A Oliver Sartor, Diogo Assed Bastos, Oren Smaletz, Jacob E Berchuck, Mary-Ellen Taplin, Rahul R Aggarwal, Cora N Sternberg, Panagiotis J Vlachostergios, Ajjai S Alva, Christopher T Su, Catherine Handy Marshall, Emmanuel S Antonarakis
Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 5 (2021)
Miguel Gonzalez Velez, Heidi E Kosiorek, Jan B Egan, Andrea L McNatty, Irbaz B Riaz, Steven R Hwang, Glenn A Stewart, Thai H Ho, Cassandra N Moore, Parminder Singh, Renee K Sharpsten, Brian A Costello, Alan H Bryce
Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer. Prostate cancer and prostatic diseases (2021)
Andrea Loehr, Akash Patnaik, David Campbell, Jeremy Shapiro, Alan H Bryce, Ray McDermott, Brieuc Sautois, Nicholas J Vogelzang, Richard M Bambury, Eric Voog, Jingsong Zhang, Josep M Piulats, Arif Hussain, Charles J Ryan, Axel S Merseburger, Gedske Daugaard, Axel Heidenreich, Karim Fizazi, Celestia S Higano, Laurence E Krieger, Cora N Sternberg, Simon P Watkins, Darrin Despain, Andrew D Simmons, Melanie Dowson, Tony Golsorkhi, Simon Chowdhury, Wassim Abida
Response to Rucaparib in BRCA-Mutant Metastatic Castration-Resistant Prostate Cancer Identified by Genomic Testing in the TRITON2 Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Takashi Tanaka, Ming Yang, Adam T Froemming, Alan H Bryce, Ryota Inai, Susumu Kanazawa, Akira Kawashima
Current Imaging Techniques for and Imaging Spectrum of Prostate Cancer Recurrence and Metastasis: A Pictorial Review. Radiographics : a review publication of the Radiological Society of North America, Inc 40 (3) (2020)
Jack R Andrews, Mohamed E Ahmed, R Jeffrey Karnes, Eugene Kwon, Alan H Bryce
Systemic treatment for metastatic castrate resistant prostate cancer: Does seqence matter? The Prostate 80 (5) (2020)
Wassim Abida, David Campbell, Akash Patnaik, Jeremy D Shapiro, Brieuc Sautois, Nicholas J Vogelzang, Eric G Voog, Alan H Bryce, Ray McDermott, Francesco Ricci, Julie Rowe, Jingsong Zhang, Josep Maria Piulats, Karim Fizazi, Axel S Merseburger, Celestia S Higano, Laurence E Krieger, Charles J Ryan, Felix Y Feng, Andrew D Simmons, Andrea Loehr, Darrin Despain, Melanie Dowson, Foad Green, Simon P Watkins, Tony Golsorkhi, Simon Chowdhury
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (11) (2020)
Thomas T DeLeon, Daniel R Almquist, Benjamin R Kipp, Blake T Langlais, Aaron R Mangold, Jennifer L Winters, Heidi E Kosiorek, Richard W Joseph, Roxana S Dronca, Matthew S Block, Robert R McWilliams, Lisa A Kottschade, Kandelaria M Rumilla, Jesse S Voss, Mahesh Seetharam, Aleksandar Sekulic, Svetomir N Markovic, Alan H Bryce
Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations. PloS one 15 (3) (2020)
Alan H Bryce, Jan B Egan, James B Smadbeck, Sarah H Johnson, Stephen J Murphy, Faye R Harris, Geoffrey C Halling, Simone B S P Terra, John Cheville, Lance Pagliaro, Brad Leibovich, Brian A Costello, George Vasmatzis
Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencing. Scientific reports 9 (1) (2019)
Michael T Barrett, Elzbieta Lenkiewicz, Smriti Malasi, Melissa Stanton, James Slack, Paul Andrews, Lance Pagliaro, Alan H Bryce
Clonal analyses of refractory testicular germ cell tumors. PloS one 14 (3) (2019)
Havell Markus, Tania Contente-Cuomo, Maria Farooq, Winnie S Liang, Mitesh J Borad, Shivan Sivakumar, Simon Gollins, Nhan L Tran, Harshil D Dhruv, Michael E Berens, Alan H Bryce, Aleksandar Sekulic, Antoni Ribas, Jeffrey M Trent, Patricia M LoRusso, Muhammed Murtaza
Evaluation of pre-analytical factors affecting plasma DNA analysis. Scientific reports 8 (1) (2018)